November 10, 2021 10:11 AM EST
News Briefing

EQT Group ac­quires VC firm in $500M+ deal; Sanofi se­lects IPO lead­ers for 2022 API spin­out — re­port

Paul Schloesser

Associate Editor

Pri­vate in­vest­ment group EQT an­nounced an agree­ment this morn­ing to buy out Life Sci­ence Part­ners, a Eu­ro­pean VC firm with more …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times